Saurav Karki, MBA, CFA: Bates White

Summary

Saurav Karki is a Principal in the Finance Practice. He specializes in providing consulting, economic, financial, and damages analysis. He advises government agencies, law firms, and industry clients on these issues in consulting engagements, arbitration proceedings, and litigation. As an expert in financial and damages analysis, Mr. Karki has worked on cases that include breach of contract, bankruptcy, employment disputes, and regulatory investigations and has broad experience in a variety of industries, including financial, cable and telecommunications, defense, pharmaceutical, hedge funds, and software.

He teaches a graduate-level course in healthcare finance at Johns Hopkins University. Mr. Karki has an MBA with a concentration in finance from Georgetown University and is a Chartered Financial Analyst (CFA) charterholder.

Education

MBA, Georgetown University

BA, Business Administration and Computer Information Systems, Wartburg College

Practices

Selected Work

Selected Experience

Retained as an expert in a case involving damages related to the alleged wrongful termination of a physician and counterclaim allegations of breach of contract. Provided analysis in support of mediation. The parties settled.
Supported the expert in a dispute among business partners regarding issues related to the structure of a sale of assets and the distribution of proceeds from the sale.
Led the team supporting the expert in performing asset tracing in connection with a bankruptcy proceeding.
Co-led the team on behalf of the Special Committee of Purdue Pharma, analyzing the value of intercompany transfers between Purdue Pharma and other entities owned by former shareholders. Performed a foreseeability analysis to evaluate debtor’s default risk over time.
Co-led team on behalf of the plaintiff in Wells Fargo Bank et al. v. Merrimack Pharmaceuticals, Inc., supporting the expert to perform a valuation of Merrimack’s pipeline of oncology drugs that supported the opinion that the sale of Merrimack’s sole commercial product constituted a fundamental change of the company.
In In re Mallinckrodt PLC, et al. supported the expert evaluating issues related to the reasonableness of opioid settlement.
Supported analysis and deposition of testifying expert on behalf of Mayagüez in Mayagüez, S.A. v. Citigroup, Inc. and Citibank, N.A.
Acted as lead consulting expert and supported the testifying expert in a case involving the calculation of net fee income and carried interest from a private equity fund.
Supported the testifying expert in Tarrus Richardson v. Tyson Pratcher and Raudline Etienne. Performed damages analysis in a lawsuit related to termination of a private equity fund manager.
Supported the testifying expert in House of Europe Funding I, LTD v. Wells Fargo et al. in a breach of contract dispute regarding the assets purchased by the asset manager and trustee of a European Collateralized Debt Obligation.
Led economic and statistical analyses for a government agency that used the results in its effort to successfully resolve a multibillion-dollar enforcement action against a major financial institution.
Supported the testifying expert in estimating lost profits from premature contract termination to distribute dental regenerative products in the North American market.
Supported the testifying expert in arbitration proceeding involving a contract dispute between defense contractors.
Supported multiple testifying experts in Novell, Inc. v. Microsoft Corp., an alleged monopolization lawsuit.

News & Insights

Publications

October 2020
Economic and potential legal implications of collateralized loan obligations
May 2020
Economic Profitability of the Biopharmaceutical Industry: 2020 update
September 2018, with appendix (updated April 2019)
Economic Profitability of the Biopharmaceutical Industry
February 19, 2018
Courts Favor Valuation Methodology Supported by Case Facts

Saurav Karki, MBA, CFA